172 related articles for article (PubMed ID: 27417316)
21. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.
Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I
Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039
[TBL] [Abstract][Full Text] [Related]
22. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
23. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
24. Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population.
Prakash R; Gupta R; Katoch VM; Tiwari PK
J Infect Public Health; 2017; 10(5):593-599. PubMed ID: 28245964
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
26. Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.
Dantas NG; Suffys PN; Carvalho Wda S; Gomes HM; de Almeida IN; de Assis LJ; Augusto CJ; Gomgnimbou MK; Refregier G; Sola C; de Miranda SS
BMC Infect Dis; 2015 Aug; 15():306. PubMed ID: 26231661
[TBL] [Abstract][Full Text] [Related]
27. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
28. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
[TBL] [Abstract][Full Text] [Related]
29. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
30. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of efficiency of nested multiplex allele-specific PCR assay for detection of multidrug resistant tuberculosis directly from sputum samples.
Mistri SK; Sultana M; Kamal SM; Alam MM; Irin F; Nessa J; Ahsan CR; Yasmin M
Lett Appl Microbiol; 2016 May; 62(5):411-8. PubMed ID: 26972777
[TBL] [Abstract][Full Text] [Related]
32. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
[TBL] [Abstract][Full Text] [Related]
33. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
[TBL] [Abstract][Full Text] [Related]
34. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea.
Yoon JH; Nam JS; Kim KJ; Choi Y; Lee H; Cho SN; Ro YT
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):52-61. PubMed ID: 22078903
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area.
Cucunawangsih ; Wiwing V; Widysanto A; Lugito NP
Int J Mycobacteriol; 2015 Dec; 4(4):302-5. PubMed ID: 26964812
[TBL] [Abstract][Full Text] [Related]
37. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
38. T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates.
Hadizadeh Tasbiti A; Yari S; Ghanei M; Siadat SD; Amanzadeh A; Tabarsi P; Saeedfar K; Bahrmand A
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S132-S133. PubMed ID: 28043507
[TBL] [Abstract][Full Text] [Related]
39. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
[TBL] [Abstract][Full Text] [Related]
40. Declining trend of resistance to first-line anti-tubercular drugs in clinical isolates of Mycobacterium tuberculosis in a tertiary care north Indian hospital after implementation of revised national Tuberculosis control programme.
Jain A; Diwakar P; Singh U
Indian J Med Microbiol; 2014; 32(4):430-3. PubMed ID: 25297031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
